This inventor holds 4 USPTO granted patents. Top assignees: Oklahoma Medical Research Foundation, Other. Active years: 1998-2005.
Location History:
- Oklahoma City, OK (US) (1998 - 2002)
- Kansas City, MO (US) (2005)
Company Filing History:
3 out of 200 
1 out of 834,350 Years Active: 1998-2005
Title: The Innovations of Ronald C. Conaway
Introduction
Ronald C. Conaway is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of molecular biology, particularly in understanding tumor suppressor complexes and RNA polymerase elongation factors. With a total of 4 patents, his work has implications for cancer research and treatment.
Latest Patents
Conaway's latest patents include groundbreaking discoveries such as the component of the von Hippel-Lindau tumor suppressor complex and SCF ubiquitin ligase - Rbx1. This evolutionarily conserved protein has been identified as a crucial part of the CUL2-containing VHL complex. Additionally, Rbx1 has been recognized as a subunit and activator of the Cdc53-containing SCF ubiquitin ligase, which is essential for the ubiquitination of the cdk inhibitor Sic1 and the G1/S cell cycle transition in yeast. The Rbx1 protein serves as a cellular marker that can help detect predispositions to certain carcinomas, act as a molecular target for therapeutic treatments, and provide insights into the complex mechanisms of cell division. Another significant patent involves ELL2, a new member of the ELL family of RNA polymerase II elongation factors. This patent discloses methods for producing ELL2 polypeptides and polynucleotides, which can be utilized in designing treatment protocols for neoplastic disorders and diagnostic assays.
Career Highlights
Throughout his career, Ronald C. Conaway has worked with esteemed organizations, including the Oklahoma Medical Research Foundation. His research has significantly advanced the understanding of cellular processes and has opened new avenues for therapeutic interventions.
Collaborations
Conaway has collaborated with notable colleagues such as Joan W. Conaway and John N. Bradsher, contributing to a rich environment of innovation and discovery.
Conclusion
Ronald C. Conaway's contributions to molecular biology and his innovative patents have had a lasting impact on cancer research and treatment methodologies. His work continues to inspire advancements in the field.